Danaher Corp (DHR)
$253.11
0.00 (0.00%)
DHR Stock Quote Delayed 30 Minutes
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
180.70B
PE Ratio
42.90
EPS
5.9
Volume (Avg. Vol.)
1,000
Day's Range
-
52-Week Range
$182.09 - $269.61
Dividend & Yield
$1.08 (0.43%)
DHR Stock Predictions, Articles, and Danaher Corp News
Danaher Stock Bubbles Near Breakout Territory as Covid-19 Testing Continues
Danaher has momentum working in its favor, as its Covid-19 testing remains strong. Let's look at DHR stock as it nears breakout territory.
Make No Mistake, Danaher Stock Is a Strong Buy
After plummeting in the pandemic selloff, Danaher stock has more than recovered. And when institutional investors return, the stock should move higher..
Danaher Stock Is a Solid Buy After Its Latest Pullback
Despite a premium valuation, Danaher is a buy in today's market. Grab DHR stock now, before shares finish bouncing back from their recent selloff.
Here’s What Makes Danaher Stock a Safe Haven During the Pandemic
Danaher stock has come under pressure like many others. But this is really an opportunity. Here's a look at why the company should hold up during the COVID-19 pandemic.
Danaher Stock Still Offers Investors the Best of Both Worlds
Danaher stock has pulled back too far, opening up a long-term value opportunity. Meanwhile, its Cepheid business can help tackle Covid-19.
3 Big Stock Charts for Friday: Nvidia, Danaher, and Crown Castle
After a day of almost normal trading on Thursday, Friday's big stock charts take the temperature of a few large-cap names.
Wait for a Pullback Before Buying Danaher Stock
2019 has been a red-hot year for Danaher stock. But as the company swallows its latest acquisitions, wait for a dip to buy the shares.
Can Danaher Carry Momentum Into 2020?
Danaher may have gotten General Electric’s life sciences business at a rock-bottom price. But once the honeymoon phase is over, DHR must actually deliver the goods.
Is General Electric Stock Worth the Risk?
General Electric stock is crawling back from a record drop after a whistleblower alleged massive fraud. Is GE stock worth the risk?
The Big Comeback for GE Stock Is Going to Keep Stalling
General Electric is doing what it's supposed to be doing, but until investors choose to see it, GE stock will remain stuck in the mud. Once they see it though, look out above.
The Problem Is, GE Stock Is Just Unknowable Right Now
Treat GE stock like a normal pick at your own peril, and take analyst views of General Electric with a grain of salt.
Best ETFs for 2019: Water Stocks and PHO Stock Finally Pull Ahead
The Powershares Water Resource Portfolio is anything but a sexy holding, but PHO stock is now beating the broad market by a wide margin.
Is Larry Culp Leading General Electric In the Right Direction?
GE stock has been a huge winner in 2019 on turnaround hopes. General Electric, however, has yet to explain the underpinnings of that turnaround.
Tuesday’s Vital Data: General Electric, Alibaba and Cisco
Options trading was buzzing in General Electric, Alibaba, and Cisco Systems on Monday. Here are the metrics that matter moving forward.
5 Top Stock Trades for Tuesday: S&P 500, Amazon and Danaher
Amazon, the S&P 500, Nio, Danaher and Cisco round out our top stock trades for Tuesday. Find out where the market's going.
Danaher Stock Surges on GE Biopharma Deal
Danaher stock was on its way up Monday following news of a deal to acquire General Electric's (GE) Biopharma business for $21.40 billion.
